Philip Morris International Announces Contract Manufacturing Arrangement For Combustible Cigarettes With Altria's Philip Morris USA; First Shipments Expected Early 2027

Altria Files Lawsuit Against The U.S. FDA In Texas; Altria Lawsuit Against The U.S. FDA Seeks To Force The FDA To Scrap Its System For Reviewing New Tobacco Products Before They Can Market

President Trump Posts On X "I am pleased to announce that Pastor Darrell Scott, a longtime friend, respected Faith Leader, and tireless Advocate for America’s Underserved Communities, will be serving my Administration and me as an Advisor for tobacco health issues on the Advisory Committee to the Director (ACD) in the CDC...."

8-K filing — ALTRIA GROUP, INC. (MO)

Filed: 2026-08-28 AccNo: 0000764180-26-000098 Size: 219 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Altria Group Raises Quarterly Dividend From $1.06 To $1.11/Share, Payable October 9 To Holders Of Record September 15

I've Been Wrong About Philip Morris International Stock for 5 Years. Here's Why I'm Finally Changing My Mind.

The author reverses his 5-year bearish stance on Philip Morris International after the company successfully pivoted from declining cigarettes to higher-margin smoke-free products. Smoke-free products now represent 42% of revenue (up from 24% in 2020), with strong growth in IQOS heated tobacco and ZYN nicotine pouches. Q2 results beat expectations with 10.4% revenue growth and 15.2% EPS growth. However, at current valuations near $192, the stock is no longer considered cheap despite the improved business fundamentals.

Altria, Philip Morris Sign Manufacturing Pact

Altria and Philip Morris International enter a contract manufacturing deal to strengthen operating capabilities.